Black Dog Institute

From SourceWatch
Jump to navigation Jump to search

The Black Dog Institute "is an educational, research, clinical and community-oriented facility offering specialist expertise in mood disorders - a range of disorders that include depression and Bipolar Disorder (formerly called 'manic depression'). The Institute is attached to the Prince of Wales Hospital and affiliated with the University of New South Wales.

"The Institute was formally launched in February 2002. The Institute builds on the work of its predecessor, the Mood Disorders Unit, established 17 years earlier as a state-wide clinical research facility." [1]

Funders [1]

Directors

On its website the Institute lists its Board of Directors, as of March 2008, as[2]:

The Institute and pharmaceutical companies

The Black Dog Institute has a policy on dealings with pharmaceutical companies which includes the Institute having to list in its Annual Report the national and international appointments and positions held by its medical staff on pharmaceutical company Advisory Boards.[3]

Sample of medical staff advisory board appointments

Medical Staff Pharmaceutical Company Advisory Board Appointments 2008 [4]
Professor Henry Brodaty Member of national advisory board: Janssen, Lundbeck, Novartis and Pfizer.
International advisory board: Elan/Wyeth and Lundbeck.
Chairman of Pfizer Neuroscience Research Grants - Australian Physicians Independent Committee and Janssen PRIME Scientific Advisory Committee.
Dr Melissa Green Reviewer for Pfizer Australia Neuroscience Research Grants.
Professor Gin Malhi Member of National Advisory Board: AstraZeneca, Eli Lilly, Glaxo Smith Kline and Wyeth Australia.
Professor Philip Mitchell Has no advisory board memberships. Gets remuneration for lectures or consultancies with AstraZeneca, Eli Lilly and Janssen-Cilag.
Professor Gordon Parker Member of Pfizer Australia Neuroscience Research Grants.
Member of National Advisory Board: Eli Lilly, Lundbeck and Janssen-Cilag.
Adviser to Servier Pharmaceuticals.
Professor Perminder Sachdev Grant assessments for Pfizer. Continuing education activities with Novartis and Eli Lilly.


Medical Staff Pharmaceutical Company Advisory Board Appointments 2006 [5]
Professor Henry Brodaty AstraZenica Advisory Board for quetiapine (Seroquel)

Janssen Chair, Dementia Advisory Board for galantamine (Reminyl) and risperidone (Risperdal)
Lundbeck, Advisory Board for memantine (Ebixa)
Novartis, Member, Australian Advisory Board for rivastigmine (Exelon)
Pfizer Chair, Australian Advisory Board for donepezil (Aricept)

Chair Pfizer Neuroscience Research Grants - Australian Physicians Independent Committee.
Professor Gin Malhi Member: AstraZeneca, Eli Lilly, Glaxo Smith Kline, and Wyeth Australia Advisory Boards
Professor Philip Mitchell Zyprexa Bipolar Depression Global Advisory Board

Efexor Global Advisory Board
Lamictal Data Safety Monitoring Board.

Consultant to Glaxo Wellcome Lamictal international studies design.
Professor Gordon Parker Member of Pfizer Australia Neuroscience Research Grants.
Member of Eli Lilly Advisory Board
Member of Lundbeck Advisory Board
Professor Perminder Sachdev Does some grant assessments for Pfizer.

Perceived conflict of interest

Henry Brodaty and Gordon Parker have had membership with the Pfizer Neuroscience Research Grants - Australian Physicians Independent Committee since its establishment in 2002[6] (Gordon Parker for 2009 is no longer listed as a member of the Committee[7] but he was listed as a member in 2008[8].)

Henry Brodaty became Chairman of the Committee in 2006[9].


Sample of Pfizer grants received by Institute researchers while Institute staff were on the Pfizer Neuroscience Research Grants - Australian Physicians Independent Committee :

  1. A 2003 funding statement from the Institute indicates Pfizer has given it a seeding grant to two Institute researchers[10].
  2. A press release dated June 16, 2004 from the media section of the Black Dog Institute announced that one of their psychiatrists has received a research grant from the Pfizer Australia Neuroscience Research Grants program.[11]
  3. A 2004 funding statement from the Institute indicating Pfizer Neuroscience Research Grants has given two grants to Institute researchers for this year[12].
  4. Pfizer Neuroscience Research Grants gave AUD$40,000 to an Institute psychiatrist in 2006 [13].

Contact

Hospital Road
Prince of Wales Hospital
Randwick NSW 2031
Phone: (02) 9382 4530
Website: http://www.blackdoginstitute.org.au

Resources and articles

Related Sourcewatch articles

References

  1. About, Black Dog Institute, accessed March 12, 2008.
  2. Directors, Black Dog Institute, accessed March 12, 2008.
  3. "Black Dog Institute and Pharmaceutical companies", Black Dog Institute website, accessed July 2009.
  4. "Black Dog Institute 2008 Yearly Report", Black Dog Institute website accessed July 2009.
  5. "Black Dog Institute Annual Report 2006", Black Dog Institute website accessed July 2009.
  6. "NSR Grants - Questions and Answers", Pfizer Australia NSR 2002 Internet archive site accessed July 2009.
  7. "Pfizer Australia Neuroscience Research (NSR) Grants - Guidelines", Pfizer Australia Neuroscience Research (NSR) Grants website accessed July 2009.
  8. "Black Dog Institute 2008 Yearly Report", Black Dog Institute website accessed July 2009.
  9. "NSR Grants - Questions and Answers", Pfizer Australia NSR 2006 Internet archive site accessed July 2009.
  10. "Black Dog Institute Funding - Funding in 2003", Black Dog Institute website accessed July 2009.
  11. "Grant For Black Dog Institute Research", Black Dog Institute website accessed July 2009.
  12. "Black Dog Institute Funding - Funding in 2004", Black Dog Institute website accessed July 2009.
  13. "Black Dog Institute Annual Report 2006", Black Dog Institute website accessed July 2009.

External resources

External articles